The Erasmus Centre for Health Economics Rotterdam (EsCHER), part of Erasmus University Rotterdam, is an internationally leading centre for health economics providing excellent research, education and job candidates. It actively engages with the public, policymakers and other healthcare stakeholders. With more than 100 health economists, EsCHER plays a prominent role in developing and applying methods that contribute to more effective, evidence-based policies and more equitable and efficient healthcare systems.

 

At Erasmus School of Health Policy & Management (ESHPM), part of Erasmus University Rotterdam, high-quality research is conducted on today’s most pressing challenges in health and social care. This research is grounded in disciplinary depth yet designed to address complex issues that require multidisciplinary collaboration. Next to research, ESHPM also offers university education. It provides a bachelor's degree, four master's degree programs and post-graduate education. By integrating current research insights into our teaching, we encourage students to adopt a broad perspective on issues in healthcare and to contribute to sustainable solutions for the future.

 

Erasmus School of Economics (ESE), part of Erasmus University Rotterdam, provides world class education in economic disciplines and econometrics. Its three main principles are quality first, integration of top research with top education, and a prime economic focus on current and future real-world questions. Within its department of Applied Economics, the Health Economics group focuses primarily on empirical micro research in health inequality, health behaviour and global health.

 

The institute for Institute for Medical Technology Assessment (iMTA), part of Erasmus University Rotterdam, is dedicated to improving decision making in healthcare. It plays a key role in HTA research in the Netherlands, in Europe and worldwide. Using perspectives from different disciplines (including economics, econometrics, medicine, psychology, epidemiology, mathematics and pharmacy), iMTA has shaped many of the key theoretical and methodological choices in the relatively young field of cost-effectiveness analysis.